Literature DB >> 1908160

Distribution patterns of apolipoproteins A1, A2, and B in the wall of atherosclerotic vessels.

E Vollmer1, J Brust, A Roessner, A Bosse, F Burwikel, B Kaesberg, B Harrach, H Robenek, W Böcker.   

Abstract

Atherosclerotic vessels were analysed histochemically for distribution, quantity, and composition of apolipoprotein (Apo) types in the vascular wall. The specimens comprised all stages of atherosclerosis, from very discrete intimal changes to complicated lesions. The vessel specimens were marked with antibodies against human Apo A1, A2, and B. Apo A1 can be demonstrated in even the earliest stage of atherosclerosis, and increases with the progression of the disease. In the initial stage, Apo A1 is found first in lumen-adjacent layers of the intima, and is evident in deeper layers of the wall as the disease progresses. Arteries of muscular type show accumulation of Apo in an earlier stage (or in greater quantity at the same stage) than arteries of elastic type. At all stages, the amount of Apo A1 always exceeds that of A2 and B. In the intima, Apo B is higher than Apo A2, the media contains hardly any Apo B, and the adventitia has less B than A2. Within the intimal layer, Apo A1 and A2 are found in an intracellular (mainly in foam cells) or in an extracellular location, according to the stage of atherosclerosis. Apo B is almost exclusively extracellular; only cases of advanced atherosclerosis show some intracellular localization (mostly in foam cells), visualized as electron dense lamellar organelles, probably of lysosomal origin. In the media, Apo A1 and A2 are accumulated in intracellular deposits, whereas the extracellular storage of Apo A1, A2 and B is observed only in cases with the most severe damage. Our investigations suggest that the accumulation of apolipoproteins in the vascular wall is affected not only by insudation from the plasma, but also by neosynthesis and/or metabolism by locally derived cells or cells immigrating in the process of atherosclerosis. The presence of Apo A1 and A2 in the vessel wall is now documented, and their role at this site apparently differs from that in the plasma.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1908160     DOI: 10.1007/bf01600220

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  44 in total

Review 1.  David M. Hume memorial lecture. Atherogenesis: recent biological concepts and clinical implications.

Authors:  H Haimovici
Journal:  Am J Surg       Date:  1977-08       Impact factor: 2.565

2.  Low density lipoprotein retention by aortic tissue. Contribution of extracellular matrix.

Authors:  S R Srinivasan; P Vijayagopal; E R Dalferes; B Abbate; B Radhakrishnamurthy; G S Berenson
Journal:  Atherosclerosis       Date:  1986-12       Impact factor: 5.162

Review 3.  High density lipoproteins and atherosclerosis.

Authors:  G J Miller
Journal:  Annu Rev Med       Date:  1980       Impact factor: 13.739

4.  Glycosaminoglycans and apolipoproteins B and A-I in human aortas. Chemical and immunological analysis of lesion-free aortas from children and adults.

Authors:  S Ylä-Herttuala; T Solakivi; J Hirvonen; H Laaksonen; M Möttönen; E Pesonen; J Raekallio; H K Akerblom; T Nikkari
Journal:  Arteriosclerosis       Date:  1987 Jul-Aug

5.  Ultrastructural localization of plasma lipoproteins in human intracranial arteries.

Authors:  H F Hoff; J W Gaubatz
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1975-12-31

6.  Immunohistochemical double labeling of macrophages, smooth muscle cells, and apolipoprotein E in the atherosclerotic plaque.

Authors:  E Vollmer; A Roessner; A Bosse; W Böcker; B Kaesberg; H Robenek; C Sorg; G Winde
Journal:  Pathol Res Pract       Date:  1991-03       Impact factor: 3.250

7.  Dietary cholesterol-induced changes in macrophage characteristics. Relationship to atherosclerosis.

Authors:  K A Rogers; R L Hoover; J J Castellot; J M Robinson; M J Karnovsky
Journal:  Am J Pathol       Date:  1986-11       Impact factor: 4.307

8.  Polyclonal antibodies against formaldehyde-modified apolipoprotein A-I. An approach to circumventing fixation-induced loss of antigenicity in immunocytochemistry.

Authors:  B Harrach; H Robenek
Journal:  Arteriosclerosis       Date:  1990 Jul-Aug

9.  Immunohistochemical localization of apoprotein B in aortas from hyperlipemic swine. Preferential accumulation in lesion-prone areas.

Authors:  D L Feldman; H F Hoff; R G Gerrity
Journal:  Arch Pathol Lab Med       Date:  1984-10       Impact factor: 5.534

10.  Serum total lipids, lipoproteins cholesterol, apoproteins A and B in cardiovascular disease.

Authors:  C Vergani; G Trovato; N Dioguardi
Journal:  Clin Chim Acta       Date:  1978-07-01       Impact factor: 3.786

View more
  7 in total

1.  Oxidation of high-density lipoprotein HDL3 leads to exposure of apo-AI and apo-AII epitopes and to formation of aldehyde protein adducts, and influences binding of oxidized low-density lipoprotein to type I and type III collagen in vitro1.

Authors:  J Greilberger; G Jürgens
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

2.  Human apolipoprotein A-I-derived amyloid: its association with atherosclerosis.

Authors:  Nahuel A Ramella; Omar J Rimoldi; Eduardo D Prieto; Guillermo R Schinella; Susana A Sanchez; María S Jaureguiberry; María E Vela; Sergio T Ferreira; M Alejandra Tricerri
Journal:  PLoS One       Date:  2011-07-19       Impact factor: 3.240

Review 3.  Atherogenesis, Transcytosis, and the Transmural Cholesterol Flux: A Critical Review.

Authors:  Doron Goldberg; Soliman Khatib
Journal:  Oxid Med Cell Longev       Date:  2022-04-14       Impact factor: 7.310

4.  LCAT, ApoD, and ApoA1 Expression and Review of Cholesterol Deposition in the Cornea.

Authors:  Rhonda Flores; Xueting Jin; Janet Chang; Connie Zhang; David G Cogan; Ernst J Schaefer; Howard S Kruth
Journal:  Biomolecules       Date:  2019-11-26

5.  Macrophage scavenger receptor A mediates adhesion to apolipoproteins A-I and E.

Authors:  Claudine Neyen; Annette Plüddemann; Pietro Roversi; Benjamin Thomas; Lei Cai; Deneys R van der Westhuyzen; Robert B Sim; Siamon Gordon
Journal:  Biochemistry       Date:  2009-12-22       Impact factor: 3.162

6.  Human apolipoprotein A-I natural variants: molecular mechanisms underlying amyloidogenic propensity.

Authors:  Nahuel A Ramella; Guillermo R Schinella; Sergio T Ferreira; Eduardo D Prieto; María E Vela; José Luis Ríos; M Alejandra Tricerri; Omar J Rimoldi
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

7.  CD36 overexpression: a possible etiopathogenic mechanism of atherosclerosis in patients with prediabetes and diabetes.

Authors:  M D Lopez-Carmona; M C Plaza-Seron; A Vargas-Candela; F J Tinahones; R Gomez-Huelgas; M R Bernal-Lopez
Journal:  Diabetol Metab Syndr       Date:  2017-07-18       Impact factor: 3.320

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.